A

Amylyx Pharmaceuticals

Biopharmaceutical company developing neurodegenerative therapies

Medical Affairs Scientific Communications and Review Consultant

Biology & BiotechPosted on Nov 13
Full-timeCambridge, MA, USA$105 - $120 /hr

About the Job

Requirements

  • An advanced scientific or clinical degree (PharmD, PhD, MD, or equivalent) is required.
  • Approximately 5–8+ years of relevant experience in pharmaceutical or biotechnology Medical Affairs, scientific communications, or related functions is required.
  • Demonstrated experience performing medical review of pharmaceutical promotional materials is required.
  • Strong experience developing scientific communications, including abstracts, posters, presentations, and/or peer-reviewed manuscripts, is required.
  • The ability to independently interpret clinical trial data and critically evaluate scientific evidence is required.
  • Strong scientific writing, analytical, and communication skills, attention to detail, and commitment to scientific accuracy and quality are required.
  • Experience collaborating with and providing scientific oversight to external medical communications agencies is required.
  • The ability to work independently, collaborate cross-functionally, manage competing priorities, and deliver high-quality work within established timelines is required.

Responsibilities

  • Serve as a primary Medical Affairs reviewer of promotional materials through the Medical, Legal, and Regulatory review process.
  • Evaluate promotional claims, clinical data presentations, references, and supporting evidence for scientific accuracy, balance, and consistency with approved product labeling; identify unsupported claims and potentially misleading interpretations.
  • Provide clear, actionable medical review comments and collaborate with Commercial, Regulatory, Legal, and Medical Affairs stakeholders to resolve scientific questions.
  • Partner with therapeutic area Medical Affairs leads on complex scientific issues and escalate matters requiring additional medical judgment.
  • Independently develop and critically review scientific materials, including abstracts, posters, oral presentations, manuscripts, slide decks, and medical education resources; verify data, references, tables, figures, and scientific claims.
  • Critically evaluate clinical trial data and scientific literature, translating findings into clear scientific narratives with consistent interpretation and presentation of the evidence.
  • Support the execution of scientific communications plans, including congress and publication activities.
  • Collaborate with Medical Affairs therapeutic area leads, biostatistics, clinical development, and other stakeholders to ensure scientific accuracy and alignment with evolving Medical Affairs priorities.
  • Provide scientific direction and oversight to external medical communications agencies, including reviewing deliverables, providing substantive feedback, and ensuring high-quality execution.

Desired Qualifications

  • Experience supporting Medical Affairs activities during prelaunch or commercial launch.
  • Experience in endocrinology, metabolic diseases, neuroscience, or rare diseases.
  • Familiarity with pharmaceutical promotional review requirements and relevant FDA regulations and guidance.
  • Experience working in a small or growing biotechnology organization.
  • Demonstrated ability to contribute to multiple scientific projects across therapeutic areas.

About the Company

Amylyx Pharmaceuticals

Biopharmaceutical company developing neurodegenerative therapies

Amylyx Pharmaceuticals develops treatments for neurodegenerative diseases, with a focus on ALS and Alzheimer's disease. Its main asset is AMX0035, currently in clinical trials, including the CENTAUR study for ALS and the PEGASUS study for late mild cognitive impairment or early dementia due to Alzheimer’s disease. The company advances products through rigorous, randomized, double-blind, placebo-controlled trials to demonstrate safety and efficacy before pursuing commercialization. In addition to research, Amylyx engages in awareness and community campaigns to support patients, caregivers, and researchers. The company aims to bring validated therapies to market to improve patient outcomes and generate revenue by selling treatments to healthcare providers and patients.

Company size
51-200
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2013

Recently Posted Jobs

Explore more opportunities at Amylyx Pharmaceuticals

See more jobs